These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8578480

  • 1. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA.
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [Abstract] [Full Text] [Related]

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J.
    Verh K Acad Geneeskd Belg; 2000 Sep; 62(5):353-72. PubMed ID: 11144685
    [Abstract] [Full Text] [Related]

  • 4. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
    Triplett DA.
    Clin Lab Sci; 1997 Sep; 10(4):223-8. PubMed ID: 10169622
    [Abstract] [Full Text] [Related]

  • 5. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T.
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [Abstract] [Full Text] [Related]

  • 6. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Dec; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 7. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA, Krilis SA.
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [Abstract] [Full Text] [Related]

  • 9. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J, Meijer P, Vermylen J.
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [Abstract] [Full Text] [Related]

  • 10. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J, Swadźba J, Jankowski M, Grzywacz M, Bazan-Socha S, Szczeklik A.
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [Abstract] [Full Text] [Related]

  • 11. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ, von Landenberg C, Barlage S, Schmitz G.
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [Abstract] [Full Text] [Related]

  • 12. The Italian Registry of Antiphospholipid Antibodies.
    Finazzi G.
    Haematologica; 1997 Apr; 82(1):101-5. PubMed ID: 9107095
    [Abstract] [Full Text] [Related]

  • 13. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D, Boutière B, Sanmarco M.
    Ann Biol Clin (Paris); 2000 Apr; 58(5):557-74. PubMed ID: 11022099
    [Abstract] [Full Text] [Related]

  • 14. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 15. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M, Finazzi G, Bevers EM, Barbui T.
    Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991
    [Abstract] [Full Text] [Related]

  • 16. [Antiphospholipid antibodies. Review].
    Diez-Ewald M.
    Invest Clin; 1993 Jul 15; 34(3):143-58. PubMed ID: 8155777
    [Abstract] [Full Text] [Related]

  • 17. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant.
    Favaloro EJ, Bonar R, Marsden K.
    Semin Thromb Hemost; 2012 Jun 15; 38(4):404-11. PubMed ID: 22565408
    [Abstract] [Full Text] [Related]

  • 18. Antiphospholipid antibodies: proposed mechanisms of action.
    Triplett DA.
    Am J Reprod Immunol; 1992 Jun 15; 28(3-4):211-5. PubMed ID: 1285881
    [Abstract] [Full Text] [Related]

  • 19. [Lupus anticoagulants versus antiphospholipid antibodies].
    Pereira MI.
    Acta Med Port; 1998 Apr 15; 11(4):349-57. PubMed ID: 9644846
    [Abstract] [Full Text] [Related]

  • 20. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO.
    Thromb Haemost; 1997 Sep 15; 78(3):1008-14. PubMed ID: 9308745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.